Tobam’s Dexcom Inc Position
Does Tobam own Dexcom Inc (DXCM)? Yes — 63.6K shares worth $4M (+1.04% of its 13F portfolio) as of Q1 2026, up from 59.9K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
63.6K
% of Portfolio
+1.04%
Quarters Held
29
currently held
Position History DXCM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 63.6K | $4M | +1.04% |
| Q3 2025 | 59.9K | $4M | +1.46% |
| Q2 2025 | 49.8K | $4M | +1.69% |
| Q1 2025 | 46.2K | $3M | +1.35% |
| Q4 2024 | 56.7K | $4M | +1.35% |
| Q3 2024 | 93.7K | $6M | +1.15% |
| Q2 2024 | 1.0K | $117,000 | +0.02% |
| Q1 2024 | 2.0K | $276,000 | +0.02% |
| Q4 2023 | 1.7K | $213,000 | +0.02% |
| Q3 2023 | 2.5K | $233,000 | +0.02% |
| Q2 2023 | 2.2K | $277,000 | +0.02% |
| Q1 2023 | 2.2K | $251,000 | +0.02% |
| Q4 2022 | 913 | $103,000 | +0.01% |
| Q3 2022 | 1.7K | $140,000 | +0.01% |
| Q2 2022 | 5.4K | $400,000 | +0.03% |
| Q1 2022 | 1.2K | $598,000 | +0.03% |
| Q4 2021 | 1.8K | $960,000 | +0.04% |
| Q3 2021 | 2.1K | $1M | +0.05% |
| Q2 2021 | 2.4K | $1M | +0.04% |
| Q1 2021 | 5.2K | $2M | +0.08% |
| Q4 2020 | 25.0K | $9M | +0.41% |
| Q3 2020 | 82.2K | $34M | +1.70% |
| Q2 2020 | 94.1K | $38M | +2.46% |
| Q1 2020 | 99.9K | $27M | +2.13% |
| Q4 2019 | 110.0K | $24M | +1.47% |
| Q3 2019 | 144.2K | $22M | +1.39% |
| Q2 2019 | 171.7K | $26M | +1.43% |
| Q1 2019 | 192.2K | $23M | +1.16% |
| Q4 2018 | 139.0K | $17M | +0.80% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tobam’s full portfolio or all institutional holders of DXCM.